AMPA receptors are the main gatekeepers of fast signaling between neurons in your brain. They are ion channels that sit on the receiving end of a nerve connection and open when the neurotransmitter glutamate binds to them, allowing a rush of positively charged ions into the cell. This electrical influx is what generates the rapid excitatory signals that underlie nearly everything your brain does, from moving your hand to forming a memory.
How AMPA Receptors Work
Every time one neuron sends a signal to another at an excitatory synapse, it releases glutamate into the tiny gap between the two cells. Glutamate molecules land on AMPA receptors embedded in the membrane of the receiving neuron, and the receptor’s channel snaps open. Positively charged ions, mainly sodium, flood inward. This depolarizes the neuron, pushing it closer to the threshold needed to fire its own electrical signal. The entire process, from glutamate binding to channel closing, takes just a few milliseconds. Desensitization (the receptor shutting down even while glutamate is still present) happens in roughly 2 to 3 milliseconds, which keeps signals crisp and prevents the neuron from being overstimulated by a single burst of glutamate.
That speed is the defining feature of AMPA receptors. They are responsible for the initial, fast component of nearly every excitatory signal in the brain. Without them, neurons would have no way to communicate rapidly enough to coordinate movement, process sensory information, or sustain conscious thought.
Structure and Subunit Combinations
An AMPA receptor is built from four protein subunits that assemble into a ring around a central pore. There are four possible subunit types: GluA1, GluA2, GluA3, and GluA4. Different combinations of these subunits create receptors with distinct properties. In the hippocampus, a brain region central to memory, most AMPA receptors are built from GluA1 paired with GluA2, or GluA2 paired with GluA3, with a smaller number made entirely of GluA1 subunits.
The subunit mix matters because it determines how the receptor behaves. Receptors containing GluA2 are impermeable to calcium, have a lower electrical conductance, and produce slightly longer-lasting currents. Receptors that lack GluA2 let calcium flow through, conduct more current, and close faster. This distinction has major consequences for both normal brain function and disease.
The GluA2 Subunit and Calcium
GluA2 is the subunit that acts as a calcium gatekeeper. After its genetic code is transcribed, an editing enzyme swaps one amino acid in the pore-lining region, changing it from a glutamine to an arginine. That single chemical change blocks calcium from passing through the channel. In a healthy adult brain, the vast majority of GluA2 subunits are edited this way, which means most AMPA receptors do not let calcium in.
When GluA2 is missing from an AMPA receptor, or when the editing process fails, the channel becomes permeable to calcium. Calcium is a powerful signaling molecule inside cells, and too much of it can trigger a cascade that damages or kills neurons. Faulty GluA2 editing has been linked to neuronal death after stroke and to some forms of the neurodegenerative disease ALS. Calcium-permeable AMPA receptors are not inherently harmful, though. They play normal roles in certain cell types and during specific stages of brain development. The problem arises when they appear where and when they shouldn’t.
AMPA Receptors and Memory
Your brain stores memories by strengthening or weakening the connections between neurons. AMPA receptors are central to this process. During long-term potentiation (LTP), the cellular mechanism most closely associated with learning, additional AMPA receptors are inserted into the synapse. More receptors at the connection means a bigger electrical response to the same amount of glutamate, effectively turning up the volume on that particular neural pathway. The reverse process, long-term depression (LTD), involves pulling AMPA receptors out of the synapse, turning the volume down.
The way receptors move in and out of synapses is surprisingly dynamic. AMPA receptors don’t just appear and disappear. They are continuously shuttled between the cell’s interior and its surface through exocytosis (insertion) and endocytosis (removal). On the cell surface, they also slide laterally along the membrane. New receptors are often inserted at locations away from the synapse and then drift sideways into the synaptic zone. When receptors need to be removed, they first slide out of the synapse to nearby regions of the membrane and are then pulled inside the cell. The narrow neck connecting a dendritic spine to the main branch of a neuron slows this lateral movement by about 2.4 times compared to the spine head, creating a natural bottleneck that helps regulate how many receptors reach or leave the synapse.
This constant cycling means the strength of a synapse is not fixed. It can be remodeled in seconds to minutes depending on the pattern of neural activity, which is why experiences can rapidly shape how your brain processes information.
AMPA vs. NMDA Receptors
AMPA receptors almost always share synaptic space with NMDA receptors, another type of glutamate-gated ion channel. The two work as a team, but they have very different jobs. AMPA receptors are fast and voltage-insensitive: they open whenever glutamate binds, regardless of the neuron’s current electrical state. NMDA receptors are slower and voltage-dependent. At the neuron’s resting voltage, magnesium ions physically block the NMDA channel, preventing current flow even when glutamate is bound. Only when the neuron is already partially depolarized (often by AMPA receptor activity) does the magnesium block get relieved, allowing the NMDA channel to open.
NMDA receptors are also permeable to calcium, which triggers the intracellular signaling cascades that drive LTP and other forms of plasticity. So the typical sequence goes like this: glutamate activates AMPA receptors first, producing a fast depolarization. That depolarization unblocks nearby NMDA receptors, which then allow calcium in and set off longer-term changes, including the insertion of more AMPA receptors. The two receptor types are functionally intertwined, with AMPA receptors handling the immediate electrical signal and NMDA receptors acting as coincidence detectors that initiate synaptic remodeling.
Links to Neurological and Psychiatric Conditions
Because AMPA receptors mediate most fast excitatory transmission, disruptions in their function can have wide-ranging effects. In epilepsy, excessive AMPA receptor activity contributes to the runaway neural excitation that produces seizures. A naturally occurring mouse mutant called the “stargazer” mouse, which lacks a protein needed to deliver functional AMPA receptors to synapses in the cerebellum, provided early evidence of how critical proper receptor trafficking is for normal brain function.
In schizophrenia, research points to decreased glutamate signaling in limbic brain structures, with both AMPA and NMDA receptors implicated. Post-mortem brain studies have found subunit-specific and region-specific changes in AMPA receptor expression in people with schizophrenia, though the exact pattern varies across brain areas. Alzheimer’s disease also involves disrupted AMPA receptor trafficking: as synapses degenerate, the normal cycling of receptors in and out of the synapse breaks down, contributing to the cognitive decline that defines the illness.
Medications That Target AMPA Receptors
Perampanel is currently the most prominent drug that acts directly on AMPA receptors. It works as a noncompetitive antagonist, meaning it binds to the receptor at a site away from the glutamate binding pocket and reduces the receptor’s activity without directly competing with glutamate. It is approved for treating partial-onset seizures in patients four years and older, and as an add-on therapy for primary generalized tonic-clonic seizures in patients 12 and older. By dampening AMPA receptor activity, perampanel reduces the excessive neuronal excitation that drives seizures. The drug carries a boxed warning for serious behavioral and psychiatric reactions, a reminder of how deeply AMPA receptors are woven into brain function beyond seizure control.